Pharma Focus Asia

University Forms Research Partnership in Precision Medicine with Bruker

Wednesday, February 14, 2024

The University of Sydney is set to lead the charge in global advancements in nanomedicine, gene therapies, and disease detection, treatment, and prevention through a strategic partnership. This collaboration aims to place the university at the forefront of precision medicine, promising tailored healthcare solutions.

In a five-year research initiative with Bruker, a renowned manufacturer of scientific instruments, the University will enhance its capabilities with the acquisition of two cutting-edge atomic force microscopes. These instruments, specialized for high-resolution imaging of living biological samples, will facilitate the visualization of dynamic molecular mechanisms and the quantification of cellular interactions. Notably, these microscopes will be the first of their kind in Australia and are expected to significantly boost biomedical and preclinical research efforts.

Dr. David Martinez Martin, a Senior Lecturer in Biomedical Engineering at the University, plays a pivotal role in driving this partnership. With a notable track record in innovation and previous collaboration with Bruker, Dr. Martinez Martin emphasizes the transformative potential of collaboration between academia and industry in addressing societal health challenges.

The University's investment in this collaboration underscores its commitment to advancing nanomedicine and related fields. Dr. Martinez Martin's expertise, combined with Bruker's resources, positions the University of Sydney as a leader in nanotechnology innovation. Atomic force microscopy, a cornerstone of this partnership, enables precise analysis and manipulation at the nanoscale, offering insights into infectious diseases, cancers, and the identification of biomarkers.

These atomic force microscopes will be housed within Sydney Microscopy and Microanalysis, an open-access research facility at the University. Associate Professor Filip Braet, Director of the facility, highlights the accessibility of these instruments to researchers across various scientific disciplines, fostering interdisciplinary discoveries.

Overall, this strategic alliance not only enhances the University's research capabilities but also promises significant societal benefits through advancements in precision medicine and nanotechnology. Dr. Martinez Martin envisions a future where this collaboration catalyzes groundbreaking innovations, highlighting the transformative potential of collaboration between academia and industry.

 

Source: sydney.edu.au

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024